Cargando…

Letter to the Editor Regarding “The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence”

Detalles Bibliográficos
Autores principales:	Finck, Barbara, Geller, Robert B., Walden, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189954/ https://www.ncbi.nlm.nih.gov/pubmed/33914268 http://dx.doi.org/10.1007/s12325-021-01694-x

Ejemplares similares

The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence
por: Feagan, Brian G., et al.
Publicado: (2020)

Letter to the Editor Regarding: Evolving Business Models in Orthotics
por: Laakso, L.
Publicado: (2022)

Letter to the Editor Regarding: Evolving Business Models in Orthotics by Schneider, N.
por: Pardy, C., et al.
Publicado: (2022)

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021)

Letter to Editor Regarding the OCEAN Study [Letter]
por: Yawn, Barbara P, et al.
Publicado: (2021)

Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit
por: Humphreys, Sophia Z., et al.
Publicado: (2022)

Biosimilar switching – current state of knowledge
por: Wiland, Piotr, et al.
Publicado: (2018)

Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
por: Subramanian, Janakiraman, et al.
Publicado: (2017)

Evolving generalists in switching rugged landscapes
por: Wang, Shenshen, et al.
Publicado: (2019)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Letter to the Editor Regarding “Blue Light Exposure: Ocular Hazards and Prevention—A Narrative Review”
por: Iqbal, Mohammed, et al.
Publicado: (2023)

Biosimilars: To switch or not to switch – that is the question
por: Szekanecz, Zoltán
Publicado: (2020)

Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016)

Letter to the editor: Regarding the editorial by Penttinen and Friede
por: Fry, Alicia M, et al.
Publicado: (2016)

Letter to the Editor: Living Donor Liver Transplantation During the COVID-19 Pandemic: An Evolving Challenge
por: Muhammad, Haris, et al.
Publicado: (2021)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

Biosimilars: Current regulatory perspective and challenges
por: Jha, Diwakar, et al.
Publicado: (2013)

Challenges in the Evolving CME Landscape
por: Gillgrass, Darren
Publicado: (2020)

Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
por: Comi, Giancarlo, et al.
Publicado: (2018)

Letter to the editor regarding “Rotavirus infection beyond the gut”
por: Orrico-Sánchez, Alejandro, et al.
Publicado: (2019)

Letter to the Editor: Regarding “The Role of Obesity in Pediatric Orthopedics”
por: Rehm, Andreas, et al.
Publicado: (2020)

Letter to the editor regarding the paper “Tick infestation of the eyelid”
por: Dantas-Torres, Filipe
Publicado: (2020)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
por: Boudier-Revéret, Mathieu, et al.
Publicado: (2022)

Letter to the editor regarding “Selfies: A boon or bane?”
por: Kazerooni, Rashid
Publicado: (2022)

Letter to the editor regarding “unusual extraneural metastasis of glioblastoma”
por: Waack, Andrew Leland, et al.
Publicado: (2023)

Letter to Editor regarding “Unusual Presentation of Spontaneous Chylothorax”
por: Varghese, Anjali Rachel, et al.
Publicado: (2022)

A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis
por: Stella, Salvatore Massimo, et al.
Publicado: (2022)

The biosimilars journey: current status and ongoing challenges
por: Kos, Igor Age, et al.
Publicado: (2018)

A Response to: Letter to the Editor Regarding “Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review”
por: Hilleman, Daniel E., et al.
Publicado: (2020)

The changing landscape of biosimilars in rheumatology
por: Dörner, Thomas, et al.
Publicado: (2016)

Letter to the editor regarding Immunoglobulin G4‐related disease in a dog
por: Watson, Penny, et al.
Publicado: (2020)

Reply to Letter to the Editor: Regarding “The Role of Obesity in Pediatric Orthopedics”
por: Nowicki, Philip, et al.
Publicado: (2020)

Letter to the editor regarding “disparities in telemedicine during COVID‐19”
por: De, Brian, et al.
Publicado: (2022)

Switching Among Biosimilars: A Review of Clinical Evidence
por: Allocati, Eleonora, et al.
Publicado: (2022)

Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilars
por: Jackisch, Christian, et al.
Publicado: (2017)

Letter to the Editor Regarding “The Evolving Impact of COVID-19 on Medical Student Orthopedic Education: Perspectives From Medical Students in Different Phases of the Curriculum”
por: Wang, Shi-Qi, et al.
Publicado: (2020)

Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn’s Disease: A Prospective Study
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2021)

Letter to the Editor Regarding Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
por: Bannenberg, Gerard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ai0rqbj5ocrjdf30eqp446019u